Breast Cancer

In recent years, the United States has seen a shift in greater awareness of the importance of SDOH and toward a more comprehensive approach to healthcare.

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

Australian researchers believe that PD-L1 may have potential as an indicator of potential response to chemotherapy in women with metastatic breast cancer. That was based on results of a randomized trial, presented at the European Society for Medical Oncology in Lugano, Switzerland.

The results show that participating in screening mammography is essential for reducing the number of deaths from breast cancer and can ultimately save lives through early detection.

Long-term adherence improvements, it appears, require personalized and sustained behavioral interventions. TMs for AI should also be personalized for individual success.

A diagnosis of vulvovaginal atrophy (VVA) in breast cancer survivors is associated with a significant increase in the burden of illness and social costs, according to an Italian Delphi Panel in the journal Supportive Care in Cancer. These findings are primarily due to a rise in comorbidities and resource utilization, but adequate treatment might reduce the impact of the condition.

Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.

Results of a new study point to a link between exposure to tamoxifen and aromatase inhibitors and reduced diagnoses of neurodegenerative diseases.

New findings shows that screening mammography that led to detection of triple-negative breast cancer (TNBC) resulted in similar outcomes for both white and African-American women.

New research from the Journal of General Internal Medicine shows that these laws are not associated with an increased understanding of the clinical implications of breast density.

While current guidelines recommend genetic testing in women with breast cancer who have relevant family history or clinical criteria, a new study examined whether it makes more sense to test all women with breast cancer.

The US Preventive Services Task Force (UPSTF) recently released an updated recommendation on medications for risk reduction of primary breast cancer and which patients would benefit most from a prescription.

The US Preventive Services Task Force (USPSTF) recently released updated recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer.

Almost 25% of women with breast cancer have a family history of the disease and, those who do have a higher risk of developing cancer.

BRCA mutation carrying mothers may have different risks depending on whether the mutation is BRCA1 or BRCA2.

Exposure to high levels of DDT is known to increase risk of breast cancer and new research examined whether age of exposure and of diagnosis are connected.

A recent study aimed to quantify the effectiveness of improvements in screening and treatment.

An examination of ACOG’s updated guidelines on breast cancer screening recommendations for the average-risk woman.

While minimally invasive and open surgeries have been found to produce similar survival rates in other early cancers, that might not be the case for early cervical cancer. PLUS: At what age should cervical cancer screening stop? ALSO: How much do genetic variants affect breast cancer risk?

Results of a new population-based study in the setting of school-based immunization and education cast doubt on speculation that teens who receive HPV vaccination practice unsafe sex. PLUS: Does 3D mammography detect more breast cancers? ALSO: Can weight loss reduce breast cancer risk in postmenopausal women?

A recent study looked at which approach to second-stage labor results in higher spontaneous vaginal delivery rates and lower rates of maternal and neonatal complications. PLUS: What makes hospitals safe for mothers and babies? ALSO: Does eating meat increase risk for breast cancer?

Babies born preterm are known to be at risk of alterations in brain structure and connectivity, but new research shows exposure to breastmilk may have cognitive benefits. PLUS: What’s behind postpartum opioid prescribing patterns? ALSO: How valuable is a second opinion for breast cancer diagnosis?

A new report shows that over a 10-year period in the United States, rates of severe maternal morbidity increased and age, race, and income, all played a role in disparities in specific related trends. PLUS: How are most women informed of a breast cancer diagnosis? ALSO: Does gestational diabetes signal long-term risk for mothers and their children?

Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.

Mammography is sufficient to predict breast cancer risk in women aged ≥ 60, but in younger women, combining mammography and genetic testing improves the assessment, according to a retrospective case-control study

A study by investigators from New England suggests that a mother’s diet during pregnancy and lactation may have an impact on the microbiome in her infant’s gut. PLUS: Are prenatal vitamin D levels tied to adverse pregnancy outcomes? ALSO: Results of a survey-based study of attending surgeons shows that they play a major role in whether women with breast cancer receive genetic testing.

While obesity has been shown to have a strong correlation with an increased risk of breast cancer in postmenopausal women, the results from a large-scale, multicenter analysis show that the inverse may actually be true for younger women. PLUS: Women with denser breast tissue have higher recall and biopsy rates and increased odds of screen-detected and interval breast cancer, according to a recent study.

Readers respond to an editorial from Dr. Lockwood on hormonal contraception and breast cancer as well as an editorial on burnout and depression in medical students.

According to research recently published in The New England Journal of Medicine, chemotherapy is not more beneficial than treatment with hormone therapy alone for women with certain types of breast cancer. Plus: Do abortions cause depression? Also: Public comments are being solicited on a new systematic review from the US Preventive Services Task Force (USPSTF) on unhealthy alcohol use in adults aged 18 and older, including pregnant women.

Since hormonal contraception was introduced in the 1960s, the risks and benefits of the drugs have been the subject of considerable, and at times acrimonious, debate.